Product Program year 2025 Source: CMS Open Payments

Oncology Testing

Device Genetics

Open in the dashboard

General payments

$2,200,093

258 payments

Research payments

$0

0 payments

Through program year 2025, $2,200,093 in general payments and $0 in research payments were reported against Oncology Testing (Genetics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $1,377,870 107
2024 General $378,566 46
2023 General $252,720 96
2022 General $190,938 9

Breakdown

Who paid General payments · program years 2022–2025
  1. Illumina, Inc. $2,200,093 258 payments
Top recipients General payments · program year 2025
  1. University Of Washington Med Ctr Teaching hospital · WA $1,348,097 98% · 10 payments
  2. Mark Ewalt Molecular Genetic Pathology · New York, NY $7,857 <1% · 4 payments
  3. Dustin Deming Medical Oncology · Madison, WI $2,226 <1% · 1 payment
  4. Aadel Chaudhuri Radiation Oncology · Rochester, MN $2,084 <1% · 1 payment
  5. Arielle Medford Internal Medicine · Boston, MA $2,084 <1% · 1 payment

The top 5 of 78 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Molecular Genetic Pathology Pathology $8,210 28% · 5 practitioners
  2. Internal Medicine $4,167 14% · 6 practitioners
  3. Medical Oncology Internal Medicine $4,107 14% · 4 practitioners
  4. Hematology & Oncology Internal Medicine $3,431 12% · 9 practitioners
  5. Anatomic Pathology & Clinical Pathology Pathology $2,203 7% · 18 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Washington $1,349,106 98% · 5 recipients
  2. New York $8,674 <1% · 8 recipients
  3. California $2,797 <1% · 12 recipients
  4. Maryland $2,520 <1% · 4 recipients
  5. Wisconsin $2,226 <1% · 1 recipient

The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

258 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record